(lp0
S"What's Next for Cubist Pharmaceuticals Inc. and Durata Therapeutics, Inc.? Motley Fool - Apr 4, 2014 Cubist Pharmaceuticals  and Durata Therapeutics  both won this week with nods by the FDA's advisory panels on each company's antibacterial agents. In two unanimous votes, the FDA panels agreed on the safety and&nbsp;..."
p1
aS'Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer PR Newswire  - Nov 17, 2014 DUBLIN, Nov. 17, 2014 /PRNewswire/ -- Actavis plc  today announced that it has successfully completed its tender offer to purchase all outstanding shares of Durata Therapeutics, Inc. , an innovative pharmaceutical company&nbsp;...'
p2
aS"Actavis agrees to acquire Durata Therapeutics MarketWatch - Oct 6, 2014 Actavis PLC reached an agreement to acquire specialty pharmaceutical company Durata Therapeutics Inc. in a deal the companies valued at about $675 million, which is expected to strengthen Actavis's business that focuses on infectious diseases.Actavis  to Acquire Durata Therapeutics  in $675M Deal - StreetInsider.com Actavis heightens M&amp;A intrigue with potential $809M Durata buy - BioWorld Online"
p3
aS'Actavis to Acquire Durata Therapeutics, Inc. PR Newswire  - Oct 6, 2014 DUBLIN, Ireland and CHICAGO, Oct. 6, 2014 /PRNewswire/ -- Actavis plc , a leading global specialty pharmaceutical company, and Durata Therapeutics, Inc. , an innovative pharmaceutical company focused on the&nbsp;...'
p4
aS'Durata Therapeutics Enters Into an Exclusive License and Supply Agreement With ... GlobeNewswire  - Jul 30, 2014 CHICAGO, July 30, 2014  -- Durata Therapeutics, Inc.  announced today that its Dutch subsidiary, Durata Therapeutics International B.V.'
p5
aS'Allergan  Updates on Durata Therapeutics Litigation; No Further ... StreetInsider.com - Apr 14, 2016 On March 16, 2016, the Court of Chancery of the State of Delaware  entered an order, pursuant to a stipulation, dismissing with prejudice as to the named plaintiffs only the action entitled In re Durata Therapeutics, Inc. Stockholders ...'
p6
aS'FDA Grants Durata Therapeutics a Special Protocol Agreement  for Its ... GlobeNewswire  - Oct 3, 2014 CHICAGO, Oct. 3, 2014  -- Durata Therapeutics  today announced that the Company has received a Special Protocol Agreement  from the Food and Drug Administration  on the design of its Phase 3 study of&nbsp;...'
p7
aS'Durata Therapeutics Announces the US Launch of DALVANCE GlobeNewswire  - Jul 18, 2014 CHICAGO, July 18, 2014  -- Durata Therapeutics, Inc.  announced today that DALVANCE  for injection is now available for use to treat adult patients with acute bacterial skin and skin structure infections&nbsp;...'
p8
aS'Durata Therapeutics Presents New Data for DALVANCE at IDWeek 2014 GlobeNewswire  - Oct 10, 2014 &quot;Our data provides additional insight into the activity of dalbavancin relative to vancomycin in the treatment of patients with ABSSSI, including those infections associated with streptococcal disease,&quot; said Durata Therapeutics Chief Medical Officer ...'
p9
aS'Dalvance by Durata Therapeutics Pharmacy Times - Jan 13, 2015 Dalvance , manufactured by Durata Therapeutics, is indicated for the treatment of acute bacterial skin and skin structure infections  caused by certain susceptible strains of Gram-positive bacteria.'
p10
a.